EGFR and non-small cell lung carcinoma: Our findings elucidate the molecular mechanisms by which TAIII overcomes acquired resistance mediated by the T790M epidermal EGFR mutation in NSCLC, which will facilitate the development of novel therapeutic strategies for drug-resistant NSCLC.